Related Experiment Video
Updated: Jan 14, 2026

09:18
Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
Published on: September 7, 2021
3.2K
Protein misfolding disorders and macroautophagy
Fiona M Menzies1, Kevin Moreau, David C Rubinsztein
1Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB 0XY, UK.
Current Opinion in Cell Biology
|November 20, 2010
Summary
Protein misfolding disorders involve protein buildup. Autophagic dysregulation contributes to this, suggesting that enhancing autophagy could be a promising therapeutic strategy for these conditions.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Protein misfolding disorders are a class of diseases characterized by the accumulation of misfolded proteins.
- These disorders present a potential therapeutic target due to the possibility of a common underlying mechanism.
- Autophagy, a cellular degradation process, is of significant interest in conditions involving cytoplasmic protein accumulation.
Purpose of the Study:
- To review the evidence linking autophagic dysregulation to protein accumulation and cellular toxicity in protein misfolding disorders.
- To explore the potential of autophagy upregulation as a therapeutic strategy for these diseases.
Main Methods:
- Literature review of studies investigating protein misfolding disorders and autophagy.
- Analysis of evidence supporting the role of autophagy in the pathogenesis of these conditions.
- Evaluation of data on the therapeutic potential of modulating autophagy.
Main Results:
- Growing evidence indicates that autophagic dysregulation contributes to protein accumulation in the cytoplasm.
- Cellular toxicity in certain protein misfolding disorders is associated with impaired autophagy.
- Upregulation of autophagy shows promise as a therapeutic approach.
Conclusions:
- Autophagic dysregulation is implicated in the pathogenesis of protein misfolding disorders.
- Enhancing autophagy represents a potential therapeutic strategy for managing these diseases.

